血脂康(胶囊)临床应用中国专家共识(2017修订版)

2018-02-07 中国老年学和老年医学学会 中华内科杂志,2018,57(2):97-100.

血脂异常是导致动脉粥样硬化性心血管疾病(atherosclerotic cardiovascular disease, ASCVD)的重要原因。近年来,我国血脂异常的患病率大幅度增加,ASCVD防治面临严峻挑战。大量临床研究证据表明,他汀类药物降低低密度脂蛋白胆固醇(low-density lipoprotein cholesterol,LDL-C),可显著减少ASCVD的患病及死亡危险。

中文标题:

血脂康(胶囊)临床应用中国专家共识(2017修订版)

发布日期:

2018-02-07

简要介绍:

血脂异常是导致动脉粥样硬化性心血管疾病(atherosclerotic cardiovascular disease, ASCVD)的重要原因。近年来,我国血脂异常的患病率大幅度增加,ASCVD防治面临严峻挑战。大量临床研究证据表明,他汀类药物降低低密度脂蛋白胆固醇(low-density lipoprotein cholesterol,LDL-C),可显著减少ASCVD的患病及死亡危险。

为进一步加强我国ASCVD的防治工作,借鉴"中国成人血脂异常防治指南(2016年修订版)" (以下简称"指南" )和近年颁布的国际血脂管理指南,对"血脂康(胶囊)临床应用中国专家共识(2009)" (以下简称"共识" )进行更新,旨在促进ASCVD的防治工作和血脂康的临床合理应用。

 

拓展指南:血脂相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=血脂康(胶囊)临床应用中国专家共识(2017修订版))] GetToolGuiderByIdResponse(projectId=1, id=217591c00155a2bb, title=血脂康(胶囊)临床应用中国专家共识(2017修订版), enTitle=, guiderFrom=中华内科杂志,2018,57(2):97-100., authorId=null, author=, summary=血脂异常是导致动脉粥样硬化性心血管疾病(atherosclerotic cardiovascular disease, ASCVD)的重要原因。近年来,我国血脂异常的患病率大幅度增加,ASCVD防治面临严峻挑战。大量临床研究证据表明,他汀类药物降低低密度脂蛋白胆固醇(low-density lipoprotein cholesterol,LDL-C),可显著减少ASCVD的患病及死亡危险。 , cover=, journalId=null, articlesId=null, associationId=1544, associationName=中国老年学和老年医学学会, associationIntro=, copyright=0, guiderPublishedTime=Wed Feb 07 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>血脂异常是导致动脉粥样硬化性心血管疾病(atherosclerotic cardiovascular disease, ASCVD)的重要原因。近年来,我国血脂异常的患病率大幅度增加,ASCVD防治面临严峻挑战。大量临床研究证据表明,他汀类药物降低低密度脂蛋白胆固醇(low-density lipoprotein cholesterol,LDL-C),可显著减少ASCVD的患病及死亡危险。 <BR><BR>为进一步加强我国ASCVD的防治工作,借鉴"中国成人血脂异常防治指南(2016年修订版)" (以下简称"指南" )和近年颁布的国际血脂管理指南,对"血脂康(胶囊)临床应用中国专家共识(2009)" (以下简称"共识" )进行更新,旨在促进ASCVD的防治工作和血脂康的临床合理应用。</P> <P> </P>拓展指南:<strong>与<font color=red>血脂</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=74a0a1c0015a49cd" title="2型糖尿病合并血脂异常的他汀类药物治疗专家共识(基层版)" target=_blank>2型糖尿病合并血脂异常的他汀类药物治疗专家共识(基层版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=b5a591c0015251ed" title="中国2型糖尿病合并血脂异常防治专家共识(2017年修订版)" target=_blank>中国2型糖尿病合并血脂异常防治专家共识(2017年修订版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c135b1c00150a2f8" title="多廿烷醇治疗老年人血脂异常的临床应用专家共识" target=_blank>多廿烷醇治疗老年人血脂异常的临床应用专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=118da1c0015005d8" title="2017年AACE/ACE血脂异常管理与动脉粥样硬化疾病预防指南简介" target=_blank>2017年AACE/ACE血脂异常管理与动脉粥样硬化疾病预防指南简介</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d7f5a1c001ae66c9" title="中国成人血脂异常防治指南(2016年修订版)亮点解读" target=_blank>中国成人血脂异常防治指南(2016年修订版)亮点解读</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%A1%80%E8%84%82" target=_blank>有关血脂更多指南</a></ul>, tagList=[TagDto(tagId=70001, tagName=血脂康)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9530, appHits=362, showAppHits=6, pcHits=6362, showPcHits=4484, likes=147, shares=17, comments=12, approvalStatus=1, publishedTime=Sun Feb 11 17:07:50 CST 2018, publishedTimeString=2018-02-07, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Feb 11 17:07:50 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:48:18 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=血脂康(胶囊)临床应用中国专家共识(2017修订版))])
血脂康(胶囊)临床应用中国专家共识(2017修订版)
下载请点击:
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1014262, encodeId=af59101426229, content=好好看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aac1957405, createdName=1e12a700m98(暂无匿称), createdTime=Fri Sep 03 12:18:46 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974483, encodeId=a29f9e4483ef, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201107/0e992c9cbb7e4bfc82d642ba0e9fe718/6fa4c63468cc49febcc91dba2fb4201a.jpg, createdBy=fa625399541, createdName=DIfh, createdTime=Thu Jun 17 21:10:17 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973901, encodeId=cd1c9e3901ad, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/5d2ea6b0af1f4647aae60bbbe8c6d7c2/899bf6408eb94ae1b00e6dfc4a71446b.jpg, createdBy=77f05472847, createdName=Misscyrq, createdTime=Tue Jun 15 22:30:32 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959916, encodeId=48d19599165d, content=他汀唯一, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=679c5272162, createdName=14825a3cm79暂无昵称, createdTime=Fri Apr 23 22:55:10 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288359, encodeId=5a1228835935, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Feb 16 08:43:14 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
    2021-09-03 1e12a700m98(暂无匿称)

    好好看看

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1014262, encodeId=af59101426229, content=好好看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aac1957405, createdName=1e12a700m98(暂无匿称), createdTime=Fri Sep 03 12:18:46 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974483, encodeId=a29f9e4483ef, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201107/0e992c9cbb7e4bfc82d642ba0e9fe718/6fa4c63468cc49febcc91dba2fb4201a.jpg, createdBy=fa625399541, createdName=DIfh, createdTime=Thu Jun 17 21:10:17 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973901, encodeId=cd1c9e3901ad, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/5d2ea6b0af1f4647aae60bbbe8c6d7c2/899bf6408eb94ae1b00e6dfc4a71446b.jpg, createdBy=77f05472847, createdName=Misscyrq, createdTime=Tue Jun 15 22:30:32 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959916, encodeId=48d19599165d, content=他汀唯一, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=679c5272162, createdName=14825a3cm79暂无昵称, createdTime=Fri Apr 23 22:55:10 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288359, encodeId=5a1228835935, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Feb 16 08:43:14 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
    2021-06-17 DIfh

    谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1014262, encodeId=af59101426229, content=好好看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aac1957405, createdName=1e12a700m98(暂无匿称), createdTime=Fri Sep 03 12:18:46 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974483, encodeId=a29f9e4483ef, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201107/0e992c9cbb7e4bfc82d642ba0e9fe718/6fa4c63468cc49febcc91dba2fb4201a.jpg, createdBy=fa625399541, createdName=DIfh, createdTime=Thu Jun 17 21:10:17 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973901, encodeId=cd1c9e3901ad, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/5d2ea6b0af1f4647aae60bbbe8c6d7c2/899bf6408eb94ae1b00e6dfc4a71446b.jpg, createdBy=77f05472847, createdName=Misscyrq, createdTime=Tue Jun 15 22:30:32 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959916, encodeId=48d19599165d, content=他汀唯一, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=679c5272162, createdName=14825a3cm79暂无昵称, createdTime=Fri Apr 23 22:55:10 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288359, encodeId=5a1228835935, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Feb 16 08:43:14 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
    2021-06-15 Misscyrq

    #心血管#好好学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1014262, encodeId=af59101426229, content=好好看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aac1957405, createdName=1e12a700m98(暂无匿称), createdTime=Fri Sep 03 12:18:46 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974483, encodeId=a29f9e4483ef, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201107/0e992c9cbb7e4bfc82d642ba0e9fe718/6fa4c63468cc49febcc91dba2fb4201a.jpg, createdBy=fa625399541, createdName=DIfh, createdTime=Thu Jun 17 21:10:17 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973901, encodeId=cd1c9e3901ad, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/5d2ea6b0af1f4647aae60bbbe8c6d7c2/899bf6408eb94ae1b00e6dfc4a71446b.jpg, createdBy=77f05472847, createdName=Misscyrq, createdTime=Tue Jun 15 22:30:32 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959916, encodeId=48d19599165d, content=他汀唯一, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=679c5272162, createdName=14825a3cm79暂无昵称, createdTime=Fri Apr 23 22:55:10 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288359, encodeId=5a1228835935, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Feb 16 08:43:14 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
    2021-04-23 14825a3cm79暂无昵称

    他汀唯一

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1014262, encodeId=af59101426229, content=好好看看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3aac1957405, createdName=1e12a700m98(暂无匿称), createdTime=Fri Sep 03 12:18:46 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974483, encodeId=a29f9e4483ef, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201107/0e992c9cbb7e4bfc82d642ba0e9fe718/6fa4c63468cc49febcc91dba2fb4201a.jpg, createdBy=fa625399541, createdName=DIfh, createdTime=Thu Jun 17 21:10:17 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973901, encodeId=cd1c9e3901ad, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/5d2ea6b0af1f4647aae60bbbe8c6d7c2/899bf6408eb94ae1b00e6dfc4a71446b.jpg, createdBy=77f05472847, createdName=Misscyrq, createdTime=Tue Jun 15 22:30:32 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959916, encodeId=48d19599165d, content=他汀唯一, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=679c5272162, createdName=14825a3cm79暂无昵称, createdTime=Fri Apr 23 22:55:10 CST 2021, time=2021-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288359, encodeId=5a1228835935, content=学习了谢谢分享!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Fri Feb 16 08:43:14 CST 2018, time=2018-02-16, status=1, ipAttribution=)]
    2018-02-16 大爰

    学习了谢谢分享!!

    0